Editorial Board

touchRESPIRATORY is currently recruiting members for the Editorial Board. If you are interested in being involved please contact: managingeditor@touchmedicalmedia.com

European Editorial Board

Andrea Aliverti - Associate Professor, Department Electronics, Information and Bioengineering (DEIB), Politecnico di Milano

Andrea Aliverti

Associate Professor, Department Electronics, Information and Bioengineering (DEIB), Politecnico di Milano

Andrea Aliverti is associate Professor at the Department Electronics, Information and Bioengineering (DEIB), Politecnico di Milano where he teaches Sensors and Instrumentation Technologies and Bioengineering of the Respiratory System. Since 2014, he is the chairman of the PhD Programme in Bioengineering at the Politecnico di Milano. He is responsible of Respiratory Analysis Lab at the Biomedical Technology Laboratory. His actual main research interests include the bioengineering of the respiratory system, physiological measurements; biomedical instrumentation and sensors; lung imaging (multivolume registration for the functional analysis of lung by CT and MRI, ultrasonography of the diaphragm; in-vivo microscopic imaging of alveolar and pulmonary vessels geometry), electrical impedance spectroscopy and monitoring of physiological variables by means of wearable unobtrusive sensors.

He is author of 130 papers in peer-reviewed scientific journals, 8 book chapters, editor of 3 books, inventor in 13 patents. He is member of the editorial board of several scientific journals and an active member of the European Respiratory Society (ERS). Currently, he is secretary of the Assembly “Clinical Physiology, Sleep and Pulmonary Circulation”, member of the ERS Education Council, Chairman of the ERS Task Force ‘Functional evaluation of lung and airways’.

Antonio Spanevello - Director of the Post-Graduate School in Respiratory Diseases, University of Insubria, Varese, Italy

Antonio Spanevello

Director of the Post-Graduate School in Respiratory Diseases, University of Insubria, Varese, Italy

Prof. Spanevello trained and developed his career in one of the most prestigious and competitive Italian University, the University of Pavia, and spent time as a visiting clinical research fellow with Dr Philip Ind and Prof. Neil Pride at Hammersmith Hospital in London in 1994-1995, where he performed important studies on induced sputum analysis in asthma.

Since then he’s been involved in a variety of clinical and translational research on the pathogenesis and clinical aspects of allergic respiratory diseases, asthma and COPD. He has a comprehensive approach to research on asthma and COPD, particularly with human studies to explore the role of inflammation (and particularly allergic inflammation) assessed with non-invasive methods, particularly sputum.

In addition to his academic activities in the University of Insubria, Varese, he has taken major managerial responsibilities by becoming Director of the Department of Respiratory Diseases of the Maugeri Foundation in Italy, where he is the Director of the Respiratory Unit of Tradate (Varese), but also of the 8 Respiratory Units of the Maugeri Foundation, ie a department of more than 200 beds.

He is the Editor of the Monaldi Archives of Chest Diseases, which is the leading respiratory journal in Italy.

He is a very active member of the ERS and is currently Secretary of the Airway Disease Assembly.

He is invited to actively participate with lectures or as a chair in more than 30 national and international conferences each year and is often interviewed by local and national newspapers and TV programs to speak on topics related to respiratory diseases.

Dave Singh - Professor of clinical pharmacology and respiratory medicine, Medicines Evaluation Unit (MEU), University Hospital Of South Manchester NHS Foundation Trust, Manchester, UK

Dave Singh

Professor of clinical pharmacology and respiratory medicine, Medicines Evaluation Unit (MEU), University Hospital Of South Manchester NHS Foundation Trust, Manchester, UK

After graduating from Cambridge University, he trained in respiratory medicine and clinical pharmacology in Manchester. He was appointed Professor of Clinical Pharmacology and Respiratory Medicine at the University of Manchester in 2011. His research interests are the pharmacotherapy of asthma and COPD, with studies spanning from basic pharmacology of anti-inflammatory drugs to clinical trials. He has acted as principal investigator on numerous clinical trials of novel therapies in asthma and COPD, and has over 130 publications in peer reviewed journals. He is a member of the GOLD science committee.

David Price - Professor of Primary Care Respiratory Medicine , University of Aberdeen; Director of Research in Real Life (RiRL), Singapore

David Price

Professor of Primary Care Respiratory Medicine , University of Aberdeen; Director of Research in Real Life (RiRL), Singapore

Fabio Midulla - University of Rome "La Sapienza"

Fabio Midulla

University of Rome "La Sapienza"

Prof. Fabio Midulla is Associate Professor of Paediatrics at the “Sapienza” University of Rome. He has been working in Pediatric pulmonology since the last 30 years. He is the author of more than 80 publications in peer-review journals. Prof. Midulla’s main activities in research are on Bronchoalveolar lavage in children and on acute bronchiolitis. He is the head of the paediatric Assembly of the European Respiratory Society.

Jean-PIerre Zellweger - Medical Adviser, TB competence Centre, Swiss Lung Association

Jean-PIerre Zellweger

Medical Adviser, TB competence Centre, Swiss Lung Association

Jean-Pierre Zellweger is a swiss pulmonary physician, with clinical experience in the management of chronic respiratory diseases, smoking cessation and tuberculosis. He was senior consultant at the University Hospital Medical Policlinic (TB department) in Lausanne. He is now medical adviser for the Swiss Lung Association, interacting with Swiss and international organizations involved in the management of tuberculosis.

Marc Miravitlles - Chest Physician and Senior Researcher, Department of Pneumology, Hospital Universitari Vall d'Hebron, Barcelona, Spain

Marc Miravitlles

Chest Physician and Senior Researcher, Department of Pneumology, Hospital Universitari Vall d'Hebron, Barcelona, Spain

Marc Miravitlles is a pulmonologist working in clinical research in the Hospital Universitari Vall d’Hebron in Barcelona, Spain. His primary research interests include chronic obstructive pulmonary disease (COPD), chronic bronchitis, alpha-1-antitrypsin deficiency (AAT), lung defence mechanisms and respiratory infections.
He serves on various medical committees and is a member of numerous professional societies, including the Spanish Society of Pneumology and Thoracic Surgery (SEPAR), where he served as Secretary from 1999 until 2003 and as responsible for International Relationships from 2006 to 2011. Dr. Miravitlles has acted as chair of the Respiratory Infections group of the European Respiratory Society (ERS) from 2008 to 2011. He has acted as a consultant for the development of different international guidelines of COPD, such as the American Thoracic Society/European Respiratory Society task force on outcomes in COPD. He was also a consultant of the Spanish Ministry of Health for the development of the National Strategy against COPD (2009 onwards). He is the coordinator of the Spanish National Guidelines for COPD (GesEPOC 2012 and update 2014). Dr Miravitlles has published numerous articles in a number of peer-reviewed international medical journals largely related to COPD, infection in COPD and alpha-1-antitrypsin deficiency.

Mário Morais-Almeida - Specialist in Allergy and Clinical Immunology and on Health Units Management, is the Head of the Allergy Center of CUF-Descobertas Hospital and CUF-Infante Santo Hospital in Lisbon and Researcher of CINTESIS – Center for Health Technology and Services Research, Porto Medical School, Portugal.

Mário Morais-Almeida

Specialist in Allergy and Clinical Immunology and on Health Units Management, is the Head of the Allergy Center of CUF-Descobertas Hospital and CUF-Infante Santo Hospital in Lisbon and Researcher of CINTESIS – Center for Health Technology and Services Research, Porto Medical School, Portugal.

His primary research interests include asthma, rhinitis, epidemiology and environmental risk factors for asthma and other allergic diseases, from pre-school age to the elderly.
He serves on various medical committees and is a member of several professional societies, international and national, including the Portuguese Society of Allergy and Clinical Immunology, where he served as President from 2005 until 2013. Dr. Morais-Almeida is the Vice-president of the Portuguese Association of Asthmatic and Allergic Patients, and has acted as Vice-president of the Latin American Allergy, Asthma and Immunology Society - SLAAI (2013-2015), President of the South European Allergy Societies - SEAS (2011), Vice-president of the Lung Portuguese Foundation (2010-2012), President of the Luso-Brazilian Society of Allergy and Clinical Immunology - SLBAIC (2009-2010) and President of the Allergy and Clinical Immunology Board of the Portuguese Medical Association (2003-2006). He act as a consultant of several departments of the Portuguese Ministry of Health for the development of the national strategy namely against asthma and anaphylaxis. He published more than 150 articles in peer-reviewed national and international medical journals largely related to asthma, rhinitis and epidemiology.

Peter Barnes - Margaret-Turner Warwick Professor of Medicine, National Heart and Lung Institute, Head of Respiratory Medicine, Imperial College, London, UK

Peter Barnes

Margaret-Turner Warwick Professor of Medicine, National Heart and Lung Institute, Head of Respiratory Medicine, Imperial College, London, UK

Peter Barnes is Margaret-Turner Warwick Professor of Medicine at the National Heart and Lung Institute, Head of Respiratory Medicine at Imperial College and Honorary Consultant Physician at Royal Brompton Hospital, London. He qualified at Cambridge and Oxford Universities (first class honours) and was appointed to his present post in 1987. He has published over 1000 peer-review papers on asthma, COPD and related topics (h-index 151) and has written or edited over 50 books. He is the 7th most highly cited researcher in the world, has been the most highly cited clinical scientist in Europe and the most highly cited respiratory researcher in the world over the last 20 years. He was elected a Fellow of the Royal Society in 2007, the first respiratory researcher for over 150 years. He has given several prestigious lectures, including Amberson Lecture at ATS and Sadoul Lecture at ERS. He was President of the ERS in 2013/2014.

Pierre Bartsch - Medical Clinic VII, Sports Medicine, University Hospital Heidelberg, Germany

Pierre Bartsch

Medical Clinic VII, Sports Medicine, University Hospital Heidelberg, Germany

US Editorial Board

Robert A Balk, MD - Pulmonary and Critical Care Medicine, Rush University Medical Center

Robert A Balk, MD

Pulmonary and Critical Care Medicine, Rush University Medical Center

Terrence Trow, MD - Director of the Pulmonary Vascular Disease Program, Yale University School of Medicine

Terrence Trow, MD

Director of the Pulmonary Vascular Disease Program, Yale University School of Medicine

Dr. Trow received his A.B. degree from Bowdoin College graduating summa cum laude and Phi Beta Kappa with highest honors in Biochemistry in 1982. He subsequently matriculated at Dartmouth Medical School, earning his MD in 1986 after being elected to the Alpha Omega Alpha Society. After a year of internship at the Hospital of the University of Pennsylvania in Philadelphia he completed his internal medicine training at The New York Hospital of the Cornell University Medical College in 1989. After a brief period as a junior faculty member at Columbia College of Physicians and Surgeons in the Emergency Medicine Division, he pursued his fellowship training at Yale University in the Section of Pulmonary and Critical Care finishing in 1993. After 9 years of service at Danbury Hospital, where he was an integral member of the house staff teaching core faculty, he was recruited to establish and build the Pulmonary Hypertension Center at Winthrop-University Hospital in Mineola, NY, an affiliate of the State University of New York at Stony Brook from 2002-2005 before being recruited to due the same at Yale University School of Medicine where he currently holds the title of Director of the Pulmonary Vascular Disease Program as well as Associate Professor of Medicine.

Dr. Trow has won a number of teaching awards including Attending of the Year at Danbury Hospital as well as Attending of the Year at Winthrop-University Hospital and has been appointed Fellow of the American College of Physicians and the American College of Chest Physicians. He served as a Deputy Editor of The Proceedings of the American Thoracic Society and served on the editorial board of Clinical Pulmonary Medicine. He is an invited reviewer for such journals as Annals of Internal Medicine, Chest, the American Journal of Respiratory and Critical Care Medicine, Heart & Lung, Southern Medical Journal, Clinical Pulmonary Medicine, and the Annals of the American Thoracic Society, Drug Design, Development and Therapy,Respiratory Medicine and Thorax. Dr. Trow also served on the Steering Committee for the Pulmonary Vascular Disease Network for the American College of Chest Physicians from 2006-2013, as well as on the Steering Committee for the Scleroderma Foundation’s National Echocardiography Education Campaign. He was recently appointed to the Scientific Leadership Council of the Pulmonary Hypertension Association and was appointed to the ACCP Task force to update the ACCP Evidence-Based Guidelines in the Pharmcologic Therapy of Pulmonary Arterial Hypertension.

Dr. Trow’s research interests are in the arena of clinical biomarkers in pulmonary hypertension. He has published widely in such journals as Chest, the Proceedings of the American Thoracic Society, Clinical Pulmonary Medicine, the Journal of Biological Chemistry, Heart&Lung: The Journal of Acute Critical Care, the Journal of Immunology, the American Journal of Physiology, the American Journal of Medicine ,Clinic in Chest Medicine, Vascular Health and Risk Management, Therapeutic Advances in Respiratory Disease, Respiratory Medicine and Thorax.

W. Michael Alberts - Moffitt Cancer Center, Professor of Oncology and Medicine, Department of Oncologic Sciences, University of South Florida College of Medicine

W. Michael Alberts

Moffitt Cancer Center, Professor of Oncology and Medicine, Department of Oncologic Sciences, University of South Florida College of Medicine